Oncologists' cost-effectiveness thresholds for new cancer therapies

被引：0

作者：

Nadler, E

Eckert, B

Neumann, P

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Harvard Univ, Boston, MA 02115 USA

来源：

VALUE IN HEALTH | 2005年 / 8卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)62576-4

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：239 / 239

页数：1

共 50 条

[41] A cost-effectiveness analysis of oral triptan therapies
Yalkowsky, RB
Malone, DC
[J]. VALUE IN HEALTH, 2002, 5 (06) : 455 - 455
[42] Cost-effectiveness analysis of current therapies for melasma
Piacquadio, DJ
Smith, S
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P175 - P175
[43] Cost-Effectiveness of Biologic Therapies in Asthma in Spain
Martinez-Moragon, Eva
[J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (10): : 621 - 622
[44] Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs
Berry, Scott R.
Bell, Chaim M.
Ubel, Peter A.
Evans, William K.
Nadler, Eric
Strevel, Elizabeth L.
Neumann, Peter J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) : 4149 - 4153
[45] On the role of cost-effectiveness thresholds in healthcare priority setting
Siverskog, Jonathan
Henriksson, Martin
[J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
[46] COST-EFFECTIVENESS THRESHOLDS: REVIEW OF CASES AROUND THE WORLD
Santos, A. S.
Guerra-Junior, A. A.
Brandao, C. M.
[J]. VALUE IN HEALTH, 2017, 20 (09) : A857 - A857
[47] Explicit Cost-Effectiveness Thresholds in Health Care: A Kaleidoscope
Jeroen Luyten
Yvonne Denier
[J]. Social Justice Research, 2019, 32 : 155 - 171
[48] Explicit Cost-Effectiveness Thresholds in Health Care: A Kaleidoscope
Luyten, Jeroen
Denier, Yvonne
[J]. SOCIAL JUSTICE RESEARCH, 2019, 32 (02) : 155 - 171
[49] Cost-effectiveness thresholds in the USA: are they coming? Are they already here?
Dubois, Robert W.
[J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (01) : 9 - 11
[50] Accounting for inflation within NICE cost-effectiveness thresholds
Low, Vincent
Macaulay, Richard
[J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (01) : 131 - 137

← 1 2 3 4 5 →